BamSEC and AlphaSense Join Forces
Learn More

Bio Green Med Solution, Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: BGMS    
Share price (7/15/26): $0.91    
Market cap (7/15/26): $4.997 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 425 48 pages Business Combination Agreement by and Among Bio Green Med Solution, Inc., Future Nrg Sdn. Bhd., and Selling Shareholders Dated as of June 4, 2026
12/34/56
EX-2.1
from 8-K 48 pages Business Combination Agreement by and Among Bio Green Med Solution, Inc., Future Nrg Sdn. Bhd., and Selling Shareholders Dated as of June 4, 2026
12/34/56
EX-2.1
from 8-K 36 pages [****] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and Would Likely Cause Competitive Harm if Publicly Disclosed. Asset Purchase Agreement by and Between Bio Green Med Solution, Inc. and Tethra Biosciences Inc. Dated as of October 6, 2025
12/34/56
EX-2
from SCHEDULE 13G/A 13 pages Amended and Restated Series B Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-2
from SCHEDULE 13G/A 13 pages Amended and Restated Series B Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-2
from SCHEDULE 13G/A 13 pages Amended and Restated Series B Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-2.1
from 425 3 pages Amendment No. 1 to Exchange Agreement
12/34/56
EX-2.1
from 8-K 3 pages Amendment No. 1 to Exchange Agreement
12/34/56
EX-2.1
from 8-K 46 pages Exchange Agreement by and Among Cyclacel Pharmaceuticals, Inc., Fitters Diversified Berhad, and Fitters Sdn. Bhd. Dated as of May 6, 2025
12/34/56
EX-2.1
from 8-K 25 pages Contents Clause
12/34/56
EX-2
from SC 13D 1 page Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.1
from DEFA14A 3 pages Amendment No. 1 to the Stock Purchase Agreement
12/34/56
EX-2.1
from 8-K 3 pages Amendment No. 1 to the Stock Purchase Agreement
12/34/56
EX-2.1
from 425 3 pages Amendment No. 1 to the Stock Purchase Agreement
12/34/56
EX-2.2
from DEFA14A 36 pages Definitions
12/34/56
EX-2.2
from 8-K 36 pages Definitions
12/34/56
EX-2.2
from 425 36 pages Definitions
12/34/56
EX-2.1
from DEFA14A 75 pages Stock Purchase Agreement Between: Xcyte Therapies, Inc., a Delaware Corporation; and Cyclacel Group PLC, a Public Limited Company Organized Under the Laws of England and Wales. Dated as of December 15, 2005
12/34/56
EX-2.1
from 8-K 75 pages Stock Purchase Agreement Between: Xcyte Therapies, Inc., a Delaware Corporation; and Cyclacel Group PLC, a Public Limited Company Organized Under the Laws of England and Wales. Dated as of December 15, 2005
12/34/56
EX-2.1
from 425 75 pages Stock Purchase Agreement Between: Xcyte Therapies, Inc., a Delaware Corporation; and Cyclacel Group PLC, a Public Limited Company Organized Under the Laws of England and Wales. Dated as of December 15, 2005
12/34/56